Author

Jessica Kristof

Observed name: J. Kristof

Observed institutions: Novartis (Switzerland), Mayo Clinic, University of California, Los Angeles, Novartis Institutes for BioMedical Research

OpenAlex ID: A5085843541

Activity of the Fibroblast Growth Factor Receptor Inhibitors Dovitinib (TKI258) and NVP-BGJ398 in Human Endometrial Cancer Cells

2013 · Gottfried E. Konecny, Teodora Kolarova, et al. · Molecular Cancer Therapeutics · 74

Occurrence of Hop Latent Viroid in Cannabis sativa with Symptoms of Cannabis Stunting Disease in California

2019 · A. Bektaş, K. M. Hardwick, et al. · Plant Disease · 26

Real-Time Reverse-Transcription Quantitative Polymerase Chain Reaction Assay Is a Feasible Method for the Relative Quantification of Heregulin Expression in Non–Small Cell Lung Cancer Tissue

2017 · Jessica Kristof, Kellen Sakrison, et al. · Biomarker Insights · 4

Abstract A208: Mutation detection in FFPE and plasma circulating DNA with a focused ALK-EGFR-KRAS Next-Generation Sequencing panel.

2013 · Peng Fang, Agus Darwanto, et al. · Molecular Cancer Therapeutics

Abstract 3491: Absolute quantification of EGFR activation and resistance mutations as well as copy number in circulating nucleic acids by droplet digital PCR.

2013 · Jessica Kristof, Eric Bruening, et al. · Cancer Research

Abstract 3490: Highly sensitive detection of EGFR T790M on Ion Torrent PGM.

2013 · Agus Darwanto, Peng Fang, et al. · Cancer Research

450 Non-invasive Absolute Quantification of EGFR Activating Mutation L858R and Gatekeeper Mutation T790M in NSCLC Plasma Samples Using Droplet Digital PCR

2012 · J. Kristof, S. Sankar, et al. · European Journal of Cancer

Works count: 7

Citation count: 104

H-index: 3

I10-index: 2